Developments of subunit and VLP vaccines against influenza A virus.
about
Replicon RNA Viral Vectors as VaccinesIdentification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in miceAlphavirus-Based Vaccines.Alphavirus-Based Vaccines.
P2860
Developments of subunit and VLP vaccines against influenza A virus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Developments of subunit and VLP vaccines against influenza A virus.
@en
type
label
Developments of subunit and VLP vaccines against influenza A virus.
@en
prefLabel
Developments of subunit and VLP vaccines against influenza A virus.
@en
P2093
P2860
P1433
P1476
Developments of subunit and VLP vaccines against influenza A virus
@en
P2093
Hua-lin Wang
Ma-ping Deng
P2860
P2888
P304
P356
10.1007/S12250-012-3241-1
P50
P577
2012-06-09T00:00:00Z
P5875
P6179
1018651780